PD-L1 in pancreatic ductal adenocarcinoma: a retrospective analysis of 373 Chinese patients using an in vitro diagnostic assay

BACKGROUND: Programmed death ligand 1 (PD-L1) has shown potential as a therapeutic target in numerous solid tumors. Its prognostic significance has also been established in pancreatic ductal adenocarcinoma (PDAC). The present study aimed to explore PD-L1 expression in PDAC cases in a large Chinese c...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Diagn Pathol
Hoofdauteurs: Liang, Xiaolong, Sun, Jian, Wu, Huanwen, Luo, Yufeng, Wang, Lili, Lu, Junliang, Zhang, Zhiwen, Guo, Junchao, Liang, Zhiyong, Liu, Tonghua
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2018
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6389094/
https://ncbi.nlm.nih.gov/pubmed/29378617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-017-0678-4
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items